Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Choosing the right guide to retirement planning is crucial for your future. Learn essential steps to secure a comfortable retirement.
22,974 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Susquehanna lifts Baidu's price target to $140 while maintaining a Neutral rating, citing AI Cloud strength but ongoi...
A claim of six primary wins is fueling talk of a pro-crypto mandate. This article breaks down what that signal could ...
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
As Hovnanian prepares to report Q2 2026 earnings, investors will scrutinize backlog, margins, and guidance. This anal...
MRED suspended its listing feeds to Zillow and Trulia, escalating a courtroom battle with Compass. The dispute could ...
When markets swing lower, the best blue chip stock often isn’t the flashiest name. This guide explains why a stalwart...
Star Wars Weekend drew $82 million in opening U.S. box office and is on track to exceed $100 million domestically, bu...
A UN FAO economist warns that fertilizer shortages and rising energy costs could push global food prices higher withi...
In 2022, the 3x levered ETF SOXL plunged about 90%, even as the broader semiconductor group endured a mid-cycle decli...
Ford just revealed a bold $2 billion energy push designed to power AI data centers. This article breaks down what the...
AMD posts robust data-center growth and free cash flow gains, while Intel sticks to its turnaround plan with heavy fo...